Potential synergy of cerebrospinal fluid TREM2 and BDNF/TrkB pathways promote mild depressive symptoms in Alzheimer's disease through tau pathology
Journal of Alzheimer’s Disease · 14.11.2026
DOI: 10.1177/13872877261503497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 14.11.2026. Verfasst von Man Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit nennt 107 Literaturangaben.
Themen: Depression, Demenz
Abstract (Originalsprache)
Background
Early identification of Alzheimer's disease (AD) remains challenging. Mild depressive symptoms (MDSs) during the prodromal stage accelerate cognitive decline, but the underlying mechanisms remain unclear. Neuroinflammation and neurotrophic support are implicated in cognitive impairment, yet the interaction between triggering receptor expressed on myeloid cells 2 (TREM2)-mediated neuroimmune dysregulation and brain derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrkB) deficits has not been established.
Objective
This study aimed to investigate whether alterations in cerebrospinal fluid (CSF) TREM2/sTREM2 and BDNF/TrkB interact to affect cognition in patients with AD and MDSs and whether tau pathology mediates this relationship, using observational data from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Methods
ADNI data collected from 2005 to 2013 included 653 eligible participants. CSF TREM2, sTREM2, BDNF, TrkB, Aβ 42 , pTau181, and tTau levels, neuropsychiatric measures, and cognitive scores were analyzed using analysis of covariance, stratified analyses, mediation analyses, and multivariable linear regression adjusted for age, sex, education, and APOE ε4 status.
Results
CSF BDNF, TREM2, and sTREM2 levels varied significantly with age. sTREM2 appeared protective in early but not late disease stages. Reduced BDNF/TrkB signaling was associated with MDSs and poorer memory and executive function. Mediation analyses indicated that MDS-related cognitive impairment was partly mediated by TREM2/sTREM2-associated neuroinflammation and BDNF/TrkB dysfunction, particularly with elevated tau pathology.
Conclusions
TREM2-mediated neuroimmune dysfunction and impaired BDNF/TrkB support may jointly exacerbate tau-related cognitive decline in preclinical AD with MDSs. This immune-neurotrophic interaction may promote dysfunctional microglial activation, excessive inflammation, and reduced clearance, offering a potential mechanism linking depressive symptoms to accelerated AD progression and informing early risk stratification and targeted intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Mental Health Center, Chongqing, China.
- Institutes of Neuroscience, Chongqing Medical University, Chongqing, China.
- Department of Neurology, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Man Zhang, Yuhao Chen, Zehu Sheng, Weihua Yu, Fan Guo, Yang Lü
Zitieren
APA
Zhang, M., Chen, Y., Sheng, Z., Yu, W., Guo, F., Lü, Y., & Alzheimer's Disease Neuroimaging Initiative (2026). Potential synergy of cerebrospinal fluid TREM2 and BDNF/TrkB pathways promote mild depressive symptoms in Alzheimer's disease through tau pathology. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261503497
Vancouver
Zhang M, Chen Y, Sheng Z, Yu W, Guo F, Lü Y, et al. Potential synergy of cerebrospinal fluid TREM2 and BDNF/TrkB pathways promote mild depressive symptoms in Alzheimer's disease through tau pathology. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261503497
BibTeX
@article{Zhang2026,
author = {Zhang, Man and Chen, Yuhao and Sheng, Zehu and Yu, Weihua and Guo, Fan and Lü, Yang and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Potential synergy of cerebrospinal fluid TREM2 and BDNF/TrkB pathways promote mild depressive symptoms in Alzheimer's disease through tau pathology},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
doi = {10.1177/13872877261503497}
}
EUVIMED